Jan Holmgren, developer of the first effective oral cholera vaccine, has been awarded the 2017 Sabin Gold Medal for his pioneering contributions to oral vaccine research and mucosal immunology, and his leadership in the discovery of the world’s first effective oral cholera vaccine.
Recipharm: Strategic appointment
AppointmentsAbivax Ebola antiviral gets financing
Latest NewsFrench virology company Abivac will receive €390,000 for the development of a polyclonal antibody cocktail to fight Ebola.
LowCross-Buffer
ProductsAntibody and sample diluent for minimizing nonspecific binding, cross-reactivities and matrix effects in immunoassays.
Centogene raises a €25m in Series A financing
Latest NewsOrphan diseases diagnostics specialist Centogene AG said it will use the funds for biomarker and CDx development based on its proprietary CentoMD mutation database.
Virbac: Managing global operations
AppointmentsBonesupport is planning €60m IPO
Latest NewsSwedish orthobiologics company Bonesupport Holding AB announced on Sunday it will go public at Nasdaq Stockholm.
Targovax raises €21m in private placement
Latest NewsNorwegian cancer med developer Targovax ASA has doubled its cash and cash equivalents as of 31 December 2016 by raising NOK200m (€21m) in a private placement of new shares.
Luminary in vaccine research
AppointmentsGrünenthal in US$300m deal with AstraZeneca
Latest NewsGerman Grünenthal Group has entered into an agreement to acquire the global rights to AstraZeneca’s migraine treatment Zolmitriptan.
Biocartis launches partnership in liquid biopsy
Latest NewsBelgian liquid biopsy specialist Biocartis Group NV has announced it will co-develop a breast cancer assay with MRC Technology.